Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn effective strategies for planning your retirement in your 40s. Ensure a secure financial future by taking proactive steps now.
10,278 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Meta has secured a patent to let an AI simulate activity on dormant or deceased accounts, a move that could reshape d...
A cluster of low-priced green stocks posted notable gains this week as renewable energy sentiment improves. Here are ...
General Mills sits near $39 after a soft quarter, boosting the dividend to about 6.3%. Retirees eyeing general mills’...
At ICE X26, MBA President Bob Broeksmit outlined how Trump orders, AI-driven underwriting, and tight housing supply a...
Best Buy’s stock soaring after a solid earnings beat, even as sales disappointed and the company trimmed its full-yea...
A concise look at the weapons that altered modern warfare and how investors are pricing defense tech in 2026.
Arizona robotics builder FrameTec is expanding its automated framing operation to slash build-cycle times and reduce ...
A private equity round closes March 19 for an IP rights company that reserved a Nasdaq ticker, signaling rising inves...
RenoFi closes a $22M Series B to scale its AI-driven renovation financing platform, triple its RENOVATION financing t...
Tesla enters a pivotal period as AI-driven software and energy products meet traditional EV growth. This article asse...
In a volatile economy, boards are adjusting performance targets to preserve executive compensation. This piece explai...